adenine has been researched along with glucagon-like peptide 1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsui, H; Miura, Y | 1 |
Hendarto, H; Hirata, E; Ikeda, N; Inoguchi, T; Maeda, Y; Sonoda, N; Takayanagi, R; Takei, R; Yokomizo, H; Zheng, J | 1 |
2 other study(ies) available for adenine and glucagon-like peptide 1
Article | Year |
---|---|
Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Calcium; Cricetinae; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Gadolinium; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isoquinolines; Male; Mesocricetus; Ouabain; Peptide Fragments; Protein Precursors; Sodium; Somatostatin; Sulfonamides; Tetrodotoxin | 2003 |
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Topics: Adenine; Albuminuria; Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucagon-Like Peptide 1; Humans; Isoquinolines; Kidney; Liraglutide; Male; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Sulfonamides | 2012 |